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CLINICAL CHARACTERISTICS AND PREVALENCE OF NECROTIZING 
ENTEROCOLITIS AMONG INFANTS WITH DYSPHAGIA USING 
SIMPLYTHICK 
ELIZABETH SPAARGAREN  
ABSTRACT 
 Introduction: Infants who have dysphagia (difficulty swallowing) are often 
recommended thickened oral liquids, which can be easier to swallow and allow infants to 
continue feeding orally. In the last decade, a xanthan gum thickener, SimplyThick®, was 
commonly used in preterm infants with dysphagia because of its ability to thicken breast 
milk.   In 2011, the FDA cautioned against the use of SimplyThick in preterm infants, 
because of case reports of necrotizing enterocolitis (NEC), a condition where the bowel 
becomes inflamed and can lead to intestinal perforation or necrosis, systemic infection, 
the failure of multiple organs and death (Moore, 2016; Press Announcements, 2011). 
However, since the FDA warning, there have been no studies examining the prevalence 
of necrotizing enterocolitis in infants who consume SimplyThick.  
 Aims: Among infants at BCH who used SimplyThick and other thickeners at <1-
year old between October 1st, 2012- December 31st, 2015 to 1) describe the patients’ 
clinical characteristics, including indications for SimplyThick and other thickeners and 2) 
determine the prevalence of necrotizing enterocolitis and adverse effects. 
 Methods: We performed a retrospective chart review in infants who had been 
seen at Boston Children’s Hospital, and prescribed or recommended SimplyThick 
thickener under the age of 1 (defined as from 0 up to and including 12 months) from 
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October 1, 2012 to December 31, 2015. We collected information from electronic 
medical records and an existing quality improvement database of infants who had an 
abnormal modified barium swallow study. We collected information regarding clinical 
variables (e.g. patient age, patient sex, patient weight, gestational age at birth, clinical 
indications), nutritional information, and outcomes (presence of NEC or other adverse 
effects). These data were entered into a REDCap database and analyzed using SAS 
statistical software. 
 Results: We identified 20 cases of infants meeting our inclusion criteria.  The 
duration of follow-up ranged from 6 months to 9.3 months.  This follow up was either 
until the case turned 12 months of age or 6 months after the use of SimplyThick if the age 
started SimplyThick was greater than 6 months old. Mean corrected age at the time that 
SimplyThick was started was 6.2 months (range, 2.7 to 10.6 months), and 6 (30%) were 
born preterm at a gestational age ranging from 24.7 to 36.5 weeks.  In cases that 
eventually stopped using SimplyThick (14 cases, 70%), SimplyThick was continued for a 
mean duration of 42.1 weeks (range 1.1 to 117.1 weeks).  The most common indications 
for SimplyThick were aspiration documented on a modified barium swallow test, 
dysphagia and GERD. The most common reasons for discontinuation of SimplyThick 
were no longer requiring thickened feeds, or needing to stop oral feeding.  No cases of 
necrotizing enterocolitis were reported among the 20 subjects. No adverse effects of 
SimplyThick were reported.   
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 Conclusion: Among 20 infants started on SimplyThick at 6.2 months and 
followed for up to 6 to 9.3 months, there were no cases of necrotizing enterocolitis. 
Further data collection is required to confirm these findings.   
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A. BACKGROUND 
  
This background section addresses: 1) the causes of feeding difficulties and why it 
is important to address these at an early age; 2) a description of dysphagia; 3) the 
rationale for thickener use to treat dysphagia; 4) the types of formula and/or breast milk 
thickeners recommended by Speech Pathologists and Gastrointestinal (GI) Specialists; 5) 
a description of necrotizing enterocolitis (NEC); and 6) a comprehensive review of the 
literature regarding the relationship between SimplyThick use and NEC. 
 
1. Feeding Difficulties 
Infancy is a critical time to learn how to feed. Early establishment of feeding 
practices during infancy allows continued advancement of feeding skills (Illingworth, 
1964). Infants with specific medical conditions, particularly preterm infants, commonly 
have feeding difficulties that interfere with advancement of feeding skills. Infants with 
immature and inadequate sucking, oropharyngeal dysphagia, and or an inability to 
coordinate breathing and swallowing, can cause feeding difficulties.  Gastroesophageal 
reflux disease (GERD) (Madhoun, 2015; Sakalidis, 2016) can also cause feeding 
difficulties.  
Dysphagia refers to difficulty swallowing liquid or food (Dysphagia, 2015).  
Dysphagia can originate from problems during any phase of chewing or swallowing as 
the food or liquid travels from the mouth, through the pharynx, and into the esophagus 
and stomach.  Problems with swallowing can result in aspiration, defined as food, liquids 
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and/or saliva passing into the airways, potentially causing breathing difficulty and other 
respiratory problems including apnea, coughing, and pneumonia. Infants with dysphagia 
may not be able to adequately nourish themselves because dysphagia-related symptoms 
may induce feeding refusal. 
Infants with dysphagia can benefit from thickened feeds. Thickened feeds 
increase the viscosity of liquids, leading to an increased oropharyngeal transit time (the 
time it takes for a bolus of food to pass the oral and pharyngeal cavities), and this slower 
transit time allows more available sensory information that will aid in the successive 
swallows (Goldfield et al., 2013). Thickened feeds are thought to improve overall oral 
motor coordination (Goldfield et al., 2013).  
Gastroesophageal reflux (GER) is a condition in which stomach fluid enters the 
esophagus, which can cause pain and/or injury to the esophageal mucosa. When the 
reflux of these gastric contents causes “troublesome symptoms and/or complications,” 
this is classified as gastroesophageal reflux disease (GERD) (NASPGHAN, 2009). 
Infants suffering with gastroesophageal reflux disease (GERD) are thought to benefit 
from thickened feeds due to an increase in weight and viscosity of the feeds, which 
reduces the likelihood that foods and stomach acid will be refluxed back up into the 
esophagus (Orenstein et al., 1987).  
 
2. Diagnosis of Dysphagia  
Methods of diagnosing dysphagia include screening with a clinical history, a 
clinical swallow assessment (CSA), and instrumental assessments such as 
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videofluoroscopy (or modified barium swallow), fibreoptic endoscopic evaluation of 
swallowing (FEES), high resolution manometry (HRM), functional lumen imaging probe 
(FLIP) and accelerometry (Rommel et al., 2015). Screening is the initial step in 
diagnosing dysphagia and uses the patient’s past medical history and presenting 
symptoms to assess his/her risk of dysphagia (Rommel et al., 2015). Screening does not 
provide information on the severity, cause or best treatment for the dysphagia. The 
components of a CSA include medical history, physical examination, clinical oral motor 
examination and an assessment of oral intake (Rommel et al., 2015). In FEES, a trained 
clinician uses a flexible laryngoscope to view the pharyngeal and laryngeal cavities 
before, during and after swallowing a bolus of food or liquid (Rommel et al., 2015). 
HRM uses a transnasal catheter with pressure sensors along the pharynx and the upper 
esophageal sphincter and measures the muscular function during swallowing (Rommel et 
al., 2015). FLIP uses a balloon at the end of an imaging probe with measures the diameter 
of the upper esophageal sphincter to assess its function and distensibility (Rommel et al., 
2015). Finally, accelerometry is cervical auscultation which involves listening to the 
cervical breath and swallowing sounds during feeding by placing the flat diaphragm of 
the stethoscope on the lateral side of the thyroid (Rommel et al., 2015).     
The modified barium swallow (MBS) test is a common diagnostic procedure that 
allows direct visualization of the swallowing mechanism, reveals the presence of 
aspiration, and informs therapeutic interventions to support safe and efficient swallowing 
(Brady et al., 2013). This test is most often performed by a radiologist and radiology 
technician. Using barium and fluoroscopy, the clinicians are able to assess the oral, 
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pharyngeal, and esophageal phases of the swallow. (Brady et al., 2013) The MBS 
radiograph shows the anatomy and physiology of the swallow as well as the airways 
before, during and after the swallow.  The goal of the MBS is to obtain as much 
information about the swallowing function with as little radiation as possible to the 
patient. The MBST is non-invasive, so it is easily available to infants who are having 
difficulty swallowing. The major disadvantage of the MBS is the radiation exposure.   
Combining the MBS with a follow-up after a changed feeding plan is effective in 
reducing cost and time in patients suffering from dysphagia (Logemann, 1997). 
Treatments following the MBS include postural interventions to assist in feeding, sensory 
enhancement techniques and therapy strategies (swallowing maneuvers). Changing the 
infant’s posture is the easiest and most effective change in swallowing dysfunction. 
Sensory enhancement techniques include a change in the sensory input or the bolus of 
food, in its temperature, texture or flavor (Logemann, 1997). This sensory enhancement 
would include a change in the bolus consistency. Throughout the MBS study, the 
practitioners can assess which bolus consistency is safe for the patient to consume and 
does not result in aspiration. Different consistencies are determined by the United States 
(US) National Dysphagia Diet, or NDD. These includes four distinct categories for 
viscosity of liquids, which are thin (1-50 mPa s), nectar-thick (51-350 mPa s), honey-
thick (351-1750 mPa s) and spoon-thick (>1751 mPa s) (September et al., 2014).  
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3. Use of Thickeners  
Thickened liquids are often recommended to treat swallowing dyscoordination in 
infants and allow safe oral feeding. This recommendation usually follows a modified 
barium swallow test, but can be made as an empiric recommendation if a clinical 
evaluation suggests aspiration of thin liquids. Use of thickening agents may reduce 
regurgitation and increase weight gain, and allow infants who might otherwise require 
enteral tube feeds to remain safe oral feeders (Horvath, 2008). 
Although thickened feeds are a common intervention to those with dysphagia, 
currently, there is no standardized system to prescribe and recommend certain types of 
thickeners. Prescribed thickener consistencies and type of thickener used for specific 
indications and patient populations is variable. This variability confuses families and at 
times may cause financial and health burdens from the prescription of one thickener over 
the other, as explained below in Section A.4.   
 
4. Types of Thickeners  
SimplyThick® 
SimplyThick is a commercial xanthan gum thickening agent that has been on the 
U.S. market since 2001. It has been commonly used in infants, because unlike other 
thickeners, it is not digested by enzymes present in breast milk, which allows it to retain 
its thickening properties when added to breast milk to feed infants (Commissioner, 2016). 
Additionally, since SimplyThick is gum-based, the time required for it to thicken either 
formula or breast milk is extremely rapid after mixing (September et al., 2014).  
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SimplyThick’s lack of flavor and the way in which it thickens compared to other 
commercial thickeners like Thick It and natural thickeners (like rice cereal and oatmeal 
cereal) has been shown to be preferred from a ranking questionnaire filled out by adult 
study participants consuming the product with other foods and drinks. (Horwarth, 2005). 
This finding may be associated with higher compliance in infants.  
The process of acquiring SimplyThick can be a difficult one for some families 
because the thickener must be either ordered online or through a pharmacy and it is 
expensive. Although SimplyThick can be ordered online without a prescription, the 
product is expensive, ranging from $35.35 per 100 nectar packets and $60.40 per 100 
honey packets (Nectar Packets, 2017). The recipes for different beverage consistencies 
using SimplyThick are described in Table 1. Many insurance companies do not cover this 
expense even when there is a prescription for the thickener. SimplyThick is also not 
readily available in grocery stores, which creates another barrier to obtaining the 
thickener. This inaccessibility of SimplyThick could lead to health disparities for families 
who can afford and are covered via their insurance to obtain SimplyThick and remain 
breast feeding, and those who are not and have to resort to cheaper, more accessible 
alternatives like rice cereal.    
 
 
 
 
 
 
 
	7 
Table 1. Consistency Recipes for SimplyThick. (Home-SimplyThick). 
Consistency Recipe  
Half-Nectar  • 7.5g	added	to	4oz	of	liquid	(formula/milk)		
• ½	“nectar”	packet	to	4oz	of	liquid	
• ½	depression	of	the	pump	to	4oz	of	liquid	
Nectar • 15g	added	to	4oz	of	liquid	(formula/milk)		
• 1	“nectar”	packet	to	4oz	of	liquid	
• 1	depression	of	the	pump	to	4oz	of	liquid	
Honey  • 30g	added	to	4oz	of	liquid	(formula/milk)		
• 2	“nectar”	packets	to	4oz	of	liquid	
• 1	“honey”	packet	to	4oz	of	liquid	
• 2	depressions	of	the	pump	to	4oz	of	liquid*	
 
*The SimplyThick gel is exactly the same in both the packets and in a bottle with pump attachment. Packets are best for 
single-use, and are easy to administer and to travel away from home. The bottle with pump attachment is more 
economical and produces less waste if the thickener use is prolonged. Either the pump or packet works effectively; it is 
up to the family which choice is best for them.   
 
Rice Cereal 
Thickening feeds with rice cereal is a common intervention for dysphagia that has 
several advantages. Rice cereal is natural, inexpensive (approximately $4/canister), and 
easily accessible because it is available at many grocers.  Rice cereal does not need a 
prescription and is less expensive than commercial thickeners. 
Rice cereal also has several disadvantages.  First, rice cereal can provide 
excessive carbohydrate calories, predisposing to rapid infant weight gain and obesity. 
Rice cereal thickened feeds result in increased carbohydrate content (with reduced 
proportion of protein and fat) in rice cereal thickened feeds can lead to excessive weight 
gain (Horvath et al., 2008).  
Second, rice cereal must be used with formula in order to thicken an infant’s 
feeds. Rice cereal cannot be used effectively with breast milk because the starch in rice 
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cereal is broken down by amylase, an enzyme in breast milk. This enzyme prohibits the 
rice cereal from thickening the breast milk, and results in a thin consistency.  
Rice cereal has also been found to induce constipation in infants when consumed 
with smaller volume feeds (Mascarenhas, 2005). Infants’ difficulty in defecation was 
common with rice cereal treatment and could be easily corrected with a change to another 
thickener, like Oatmeal Cereal.  
Alternatively, when thickening with rice cereal, the resulting liquid must have a 
very smooth consistency otherwise it will lead to a decrease in flow rate which may result 
in more energy exerted from the infant and less actual consumption of the feeds 
(September et al., 2014). This hindering extraction of thickened liquids from the bottle (at 
times stuck in the bottle nipple) can lead to the infant consuming less due to exhaustion. 
Starch thickeners take time to reach their optimum viscosity with an initial spike 
in thickening, followed by a slower increasing, less steep thickening. The total time until 
a starch-thickened feeds is completely stable is estimated to be an average of 10 minutes 
(September et al., 2014).  The reason for this delay in thickening is related to the structure 
of starch. Starch is a carbohydrate consisting of many glucose units which cluster into 
side chains. Starch is used to store energy and is produced by most green plants (Pérez et 
al., 2010).  Starch’s porosity is very compact caused by crystalline and amorphous 
lamellae that branch off from amylopectin molecules (Pérez et al., 2010). This means that 
the starch is not able to hydrate very quickly, and is slower than gum-based thickeners to 
thicken feeds.  
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There is also mounting concern regarding adverse effects of arsenic exposure 
from rice (Arsenic in Rice and Rice Products Risk Assessment Report, 2016). Arsenic is 
a class one carcinogen which can be found in the air, bedrock, pesticides and 
contaminated ground water (ARSENIC AND ARSENIC COMPOUNDS, 2001). Arsenic 
is able to bioaccumulate in rice plants which places individuals who are highly dependent 
on rice products at risk for adverse effects such as lung and bladder cancer (Tsuji et al., 
2014).  One study showed that infants who consume rice cereal (geometric mean [GM] at 
5.83 µg/L; 95% CI, 4.23-8.05 µg/L) have on average more than double the total urinary 
arsenic concentration than infants who do not consume rice cereal (GM at 2.85 µg/L; 
95% CI, 2.42-3.34 µg/L) (Kargas et al, 2016).  Further studies are needed to assess the 
long term exposure of rice cereal in infants.  
 
Gelmix™  
Gelmix™ is another commercial thickener which is prepared as a powder. This 
powder is formed from an organic carob bean gum, also known as locust bean gum and 
tapioca maltodextrin (About Gelmix Thickener). The benefits of Gelmix are that it can be 
used with both formula and breast milk and it is fat-free and low in calories. The Gelmix 
Company boasts that it is the first and only USDA certified organic pediatric thickener.  
The disadvantages of Gelmix are its preparation and price/availability. Gelmix is 
not available in stores, so similar to SimplyThick, families would need to order online or 
receive samples from a clinician. Gelmix is more expensive than SimplyThick and rice 
cereal, costing about $80/100 packets (About Gelmix Thickener). The preparation of 
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Gelmix-thickened feeds requires more effort than the other thickeners. As outlined on the 
Gelmix website, the caregiver must first warm the desired liquid to 100-120 degrees 
Fahrenheit, then add the powdered Gelmix, mix well and then wait until the temperature 
of the now thickened liquid is appropriate enough to feed the infant. The liquid may 
require reheating if the Gelmix does not completely mix initially. The temperature of the 
breast milk or formula that the infant should be receiving should be slightly below body 
temperature (98.6 degrees Fahrenheit). The liquid should not be too hot to avoid burning 
the infant and not too cold to avoid constriction of the blood vessels of the gut, restricting 
blood flow and oxygen delivery to the infant (Stokowski, 2008). This time consuming 
and temperature sensitive process may dissuade families from using this thickener.  
The agent in the Gelmix powder has also been described in 2004 to be a risk 
factor for developing NEC (Clarke et al., 2004). More on this is described in Section A. 
6.  
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Table 2. Summary of Formula/Expressed Breast Milk (EBM) Thickeners. The graph below shows the types of 
liquids that can be used in conjunction with each thickener, how they are prepared and the pros and cons of each 
thickener described in this study.  
 
Thickener Type  Can be used with 
EBM and/or 
Formula? 
Preparation  Pros  Cons  
SimplyThick EBM + Formula  Add the packet or 
pump the gel into 
the liquid, mix 
thoroughly.  
• can be used with 
breast milk 
• little carbohydrates 
added  
• will not clog bottle 
nipples 
• possible onset of 
NEC  
Rice Cereal  Formula  Add cereal to 
formula, mix 
thoroughly.  
• less expensive  
• can be 
recommended for 
infants at any age 
• Possible arsenic 
exposure  
• cannot use with 
breast milk 
• added carbohydrates 
may clog bottle 
nipples 
Gelmix  EBM + Formula  Must heat 
formula/EBM 
before adding to 
completely dissolve. 
Wait until 
appropriate 
temperature for 
feeding.  
• can be used with 
breast milk  
• temperature 
sensitive  
• difficult to use  
 
 
Benefits of Breast Milk 
SimplyThick’s primary advantage over other thickeners is its ability to easily mix 
well and thicken breast milk. Not only is the xanthan gum not broken down by the breast 
milk enzyme amylase, but the gum also mixes very easily and quickly with the breast 
milk without any temperature change or wait.  
Feeding with breast milk is the gold standard for infants, as supported by the 
American Academy of Pediatrics (AAP) and others because of breast milk’s positive 
effects on both maternal and infant health outcomes (Breastfeeding, 2012). The AAP 
describes breastfeeding as the best option for the baby, the mother, the family and the 
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community (AAP). Breastfeeding benefits the baby by decreasing the infant’s risk of 
infectious diseases and viruses. Breastfeeding benefits the mother by producing a reduced 
risk of breast and ovarian cancer (Breastfeeding, 2012). Breastfeeding benefits the family 
though facilitating bonding, and it benefits the community through being an economic, 
green and clean alternative to formula feeding (AAP).  
A meta-analysis of 4 randomized clinical trials done from 1983 to 2005 found that 
infants with a history of breastfeeding had a decreased risk of “acute otitis media, non-
specific gastroenteritis, severe lower respiratory tract infections, atopic dermatitis, asthma 
(young children), obesity, type 1 and 2 diabetes, childhood leukemia, sudden infant death 
syndrome (SIDS), and necrotizing enterocolitis” (Ip et al., 2007). Feeding infants with 
breast milk was also associated with a 58% reduction in the incidence of NEC (Ip et al., 
2007). In 2010, a randomized controlled multicenter trial was performed to compare the 
rates of NEC development in premature infants who were exclusively fed with human 
breast milk to those who were fed a diet of human and bovine milk-based products 
(Sullivan et al., 2010). The multivariate regression revealed an odds ratio for NEC with 
exclusive human milk diet to be 0.23 (95% confidence interval 0.08-0.66, P=.007), or a 
77% reduction in the odds of developing NEC while on an exclusive human milk diet as 
compared to a human and bovine-milk diet (Sullivan et al., 2010).  
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5. Necrotizing Enterocolitis  
Necrotizing enterocolitis is one important cause of morbidity and mortality in 
infants in the United States (Guthrie, 2003). Prematurity, enteral feeding and bacterial 
overgrowth are all predisposing factors for NEC, a multifactorial, and incompletely 
understood disease (Woods et al., 2012). Breastfeeding is thought to lower the risk of 
development of NEC.  
NEC is a condition where the bowel becomes inflamed and can lead to intestinal 
perforation or necrosis, systemic infection, the failure of multiple organs and death 
(Moore et al., 2016). During NEC, tight junctions in the GI tract mucosa involved in 
creating a physical barrier against substances such as antigens, bacteria and digestive 
enzymes, are disrupted, creating increased permeability in the intestinal lumen which 
may lead to mucosal injury and inflammation (Moore et al., 2016). The usual time for 
NEC to present is within the first month of life and NEC most commonly involves the 
disruption of the ileum (Woods et al., 2012). 
NEC is classified by clinical criteria including “one or more of the following 
clinical signs: bilious, gastric aspirate or emesis, abdominal distention, or occult or gross 
blood in stool without evidence of a rectal fissure; and has one or more of the following 
radiographic findings: pneumatosis intestinalis, hepatobiliary gas, or pneumoperitoneum” 
(Bell et al., 1978). This inflammatory bowel disease is best defined through a method of 
clinical staging further described in Table 3. Stage I indicates evidence of NEC and 
further tests are appropriate. Stage II diagnosis is where NEC is definitive and patients 
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are treated medically and the finally stage III requires operation (Bell 1978). Operations 
for NEC have a high mortality rate in neonates with some studies suggesting a 24% death 
rate (Guthrie, 2003).  
 
Table 3. Stages of NEC. (Bell 1978). 
Stage of NEC  Diagnosis Signs/Symptoms Treatment 
Stage I Suspect • Systemic Manifestations: 
temperature instability, 
lethargy, apnea, 
bradycardia 
• GI Manifestations: poor 
feeding, increased pre-
gavage residuals, emesis, 
mild abdominal distention, 
occult blood may be in 
stool  
• Abdominal Radiographs: 
distention with mild ileus 
• Blood culture 
• IV fluids 
• IV antibiotics  
Stage II Definite  • Above signs and 
symptoms 
• Persistent occult or gross 
GI bleeding, marked 
abdominal distention 
• Abdominal Radiographs: 
significant intestinal 
distention, small bowel 
separation, unchanging or 
persistent “rigid” bowel 
loops, pneumatosis 
intestinalis, portal vein gas 
• Above treatment 
plus an 
aminoglycoside 
antibiotic 
administered  
Stage III Advanced  • Above signs and 
symptoms  
• Deterioration of vital signs, 
evidence of septic shock or 
marked GI hemorrhage  
• Abdominal Radiographs: 
stage II findings plus 
pneumoperitoneum 
• Operative 
Intervention  
 
6. Review of Current Literature  
In September 2012, the FDA issued a statement that because of 22 case reports of 
infants developing necrotizing enterocolitis after taking SimplyThick, that infants at any 
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age are at increased risk and for families to be cautious when choosing to use the 
thickener. The oldest case gestational age in that report was unknown, but many hospitals 
across the U.S. have stopped using SimplyThick for preterm infants under 1 year 
corrected age.   
The first description of the possible association between thickened feeds and NEC 
was observed in 2004. The letter describes two cases of fatal NEC, both infants 
consuming the carob bean gum thickening agent, “Carobel” (Clarke et al., 2004). The 
research hypothesized that the thickener caused bacterial overgrowth in the bowels 
leading to NEC. Although both infants described were taking Carobel as a formula 
thickener, they also were both extremely low birth weight and premature, which are also 
possible underlying causes for the development of NEC (Schnabl et al., 2008)   
Another study in 2010 described the potential risk factors for NEC including 
maternal risk factors as well as clinical conditions (Drenckpohl et al., 2010). Statistically 
significant clinical risk factors for NEC were sepsis, receiving H2 blockers via total 
parental nutrition, race (with African Americans developing NEC more), and premature 
rupture of the membranes (PROM) resulted in increased odds for developing NEC 
(Drenckpohl et al., 2010). This study did include thickener use in the clinical conditions, 
but did not find their use to be statistically significant in calculating the odds of the infant 
developing NEC. This study also examined many potential confounding variables for the 
onset of NEC in those patients who did use a feed thickener. Some of these risk factors 
and variables were prematurity, the clinical conditions listed above and the maternal risk 
factors of PROM and preeclampsia.  
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On May 20th, 2011, the US Food and Drug Administration (FDA) issued an 
advisory about the potential risk of developing necrotizing enterocolitis after infant 
consumption of SimplyThick (Press Announcements, 2011). The FDA’s first adverse 
event report to SimplyThick was recorded on March 13th, 2011, when a team was then 
compiled to research the possible other cases. The advisory initially warned against using 
the formula thickener in preterm (<37 weeks gestation) infants. The FDA then expanded 
this warning to infants of any age, saying that all infants may be at increased risk of NEC 
if consuming SimplyThick.  
A case series of 3 infants who used SimplyThick and developed NEC were 
described in a publication in 2012 (Woods et al., 2012). It is unclear if these infants were 
included in the FDA advisory. The three cases all developed NEC in their second 
postnatal month with the necrosis predominantly in their colon. In contrast, typical NEC 
diagnoses occur within the first month of life and involve the ileum (Woods et al., 2012). 
These cases raised concern for the association between NEC and SimplyThick because 
the infants developed NEC well after term age or discharge from the hospital, which is 
older than NEC typically presents. Two out of the three cases were formula fed, and not 
breast fed. Breast milk is known to be protective against NEC.  
Physicians working with the FDA compiled a descriptive case study of the illness 
reports to the adverse events reporting. The study defined cases as infants exposed to 
SimplyThick who were diagnosed with NEC who have radiographic evidence of 
pneumatosis intestinalis, portal vein gas, and/or absent radiographs who also have a 
surgical and/or autopsy confirmation of the diagnosis (Beal et al., 2012). Out of the 84 
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illness reports, 22 met these criteria. Twenty-one out of the twenty-two cases were 
premature, and the median number of days after consumption of SimplyThick to acquire 
the onset of NEC was approximately 13 days. The study provides a possible explanation 
for the development of NEC after consumption of SimplyThick. Through the bacterial 
metabolism of SimplyThick’s xanthan gum, there could be an accumulation of short 
chain fatty acids which could induce mucosal injury to the intestines and result in NEC 
(Beal et al., 2012). The main limitation with this study is that the data does not provide 
exact clinical data for each case, and merely summarizes all 22 cases with median and 
mean values. This is does not allow the reader to develop an accurate picture of which 
infants are developing NEC and possible confounding variables that could lie within the 
data. Additionally, this case series shows a correlation and not causation.  
Other than these studies, there has been little research performed since 2012 on 
the effects of SimplyThick and if it is a risk factor for NEC. Some previous studies 
described the physiology of short chain fatty acids in mice and the relation of GI issues, 
but the results were inconclusive (Mortensen et al., 1996).  
Although there have been some concerns from the FDA about using SimplyThick 
due to NEC onset, and other thickeners such as Gelmix and rice cereal have their own 
problems, a recent study showed that 79% of neonatal feeding providers still recommend 
thickeners (Madhoun et al., 2015). Thickening is a prevalent feeding strategy for infants 
who suffer from dysphagia, GERD, aspiration and other feeding difficulties. With the 
extreme benefits of using SimplyThick due to its ability to be easily mixed with breast 
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milk without temperature sensitivity, further studies need to be conducted to shed light on 
the actual incidence rate of those who use SimplyThick and subsequently develop NEC.  
In summary, infancy is a critical time to learn how to feed; failure to establish oral 
feeding during critical developmental windows in infancy can lead to oral aversion that is 
not easily treated.  Establishment of safe oral feeding in infants with dysphagia or 
oromotor dyscoordination can be difficult, and may require the use of thickened liquids. 
Use of thickening agents may reduce regurgitation and increase weight gain, and allow 
infants who might otherwise require enteral tube feeds to remain safe oral feeders 
(Horvath et al., 2008).  SimplyThick, a commercial xanthan gum thickening agent that 
has been on the U.S. market since October 2001, has been commonly used in infants with 
dysphagia, because unlike other thickeners it is not digested by enzymes present in breast 
milk, allowing it to retain its thickening properties when added to breast milk. However, 
if SimplyThick predisposes infants to NEC, other thickeners may be associated with 
similar risks since the mechanism underlying the association is unknown. Current clinical 
practice restricting SimplyThick use to children > 12 months old has removed an 
important tool in supporting feeding development in infants with swallowing 
dyscoordination for breastfed infants, forcing practitioners to choose between enteral 
tube-delivered expressed breast milk feeds, or thickened formula oral feeds with 
cessation of breast milk and its many health benefits.  Infants placed on enteral tube feeds 
(i.e. g-tubes) on average have more hospital admissions and hospital days per year than 
infants using thickened feeds (McSweeney 2016). A clearer understanding of the risk of 
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NEC associated with SimplyThick use is urgently needed to assist practitioners in clinical 
decision-making. 
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B. SPECIFIC AIMS  
 
 The objective of the present study is to describe the use of SimplyThick and its 
association with NEC in infants at BCH. Among infants at BCH who used SimplyThick 
and other thickeners at <1-year old between October 1st, 2012-December 31st, 2015, the 
specific aims are: 
1.) To describe the patients’ clinical characteristics, including indications for 
SimplyThick and other thickeners.  
2.) To determine the prevalence of necrotizing enterocolitis and adverse effects.  
 
Hypotheses 
The prevalence of necrotizing enterocolitis will be < 5% among children using 
SimplyThick.  
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C. CONCEPTUAL MODEL 
 
 
  
Figure 1. Conceptual Model. This figure displays the three aims of the study as well as the possible confounding 
variables of the exposure to SimplyThick and development of Necrotizing Enterocolitis. 
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Confounding Variables  
Prematurity has been shown to be one of the predominant risk factors and one 
possible confounding variable in the cases of infants who were premature, used 
SimplyThick and developed NEC. Prematurity increases the risk that a thickener will be 
recommended, because many premature infants have developmental delays in oral motor 
coordination. The premature infant’s “immature mobility, digestion, absorption, immune 
defense [and] barrier function” (Neu et al., 2011) are thought to predispose these infants 
to NEC. The structural or biochemical immaturity of the intestinal epithelial barrier may 
allow bacteria to gain access and cause intestinal inflammation (Schnabl et al., 2008). In 
animal models, data suggest that the breakdown of xanthan gum into short chain fatty 
acids (SCFA) in the intestine results in the accumulation of SCFA, causing irritation and 
inflammation leading to NEC (Mortensen et al., 1996).  
Enteral feeding has a very strong association with NEC, and “90%-95% of NEC 
cases occur in infants with initiation/ re-initiation of enteral feeds or recent volume 
advancement” (Schnabl et al., 2008). Enteral feeds may disrupt the integrity of the 
intestinal mucosa and reduce blood flow.  
Many preterm infants suffer from hypoxia or hypotension which can be 
associated with ischemia.  Hypoxia and ischemia modulate the balance of microvascular 
tone, which has an effect on downstream regulators of vascular tone like nitric oxide and 
endothelin that may play a role in the pathophysiology of NEC (Neu et al., 2011). 
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Cardiac disease can also lead to a restriction of blood supply to the intestines (ischemia) 
predisposing to NEC.  
H2-Inhibitors and proton pump inhibitors, commonly used in GER or GERD to 
reduce gastric acidity, have been associated with a higher incidence of NEC (Guillet et 
al., 2006). The Guillet et al. study concluded that an alkaline gastric pH level may be a 
factor in the development of NEC (Guillet et al., 2006). Because GER and GERD may 
also be indications for the use of SimplyThick, the use of acid-blocking medications may 
confound the relationship between SimplyThick and NEC. 
 The use of other types of thickeners before, during or after the use of 
SimplyThick may also confound the relationship of SimplyThick with NEC. Multiple 
thickeners can be used in one patient for many reasons such as the patient did not tolerate 
the original thickener, the original thickener was difficult to get a supply of, or the 
original thickener was too expensive for the family. Since the underlying mechanism for 
SimplyThick to predispose to the development of NEC is still unknown, other thickeners 
could have similar clinical effects on the development of NEC.  
 As discussed above in section A. 4, formula-feeding predisposes to NEC and 
could also be a potential confounder.  
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D. METHODS 
 
Study Design  
We conducted a retrospective cohort study reviewing patient charts from October 
1, 2012 through December 31, 2015. These dates were chosen to occur after the FDA 
statement regarding the association of SimplyThick and NEC in September 2012.  In 
October 2012, a multidisciplinary committee at BCH recommended that SimplyThick be 
discontinued in infants <52 weeks postmenstrual age.  
 
Inclusion and Exclusion Criteria 
To identify eligible subjects who took SimplyThick, we first obtained IRB 
approval for this retrospective chart review, then we used the i2B2 electronic research 
database to identify children under the age of 1 year (0 to 12 months) corrected age at the 
date that SimplyThick was prescribed for the first time between October 1, 2012 and 
December 31, 2015. We obtained data for each infant for a minimum of 6 months after 
the use of SimplyThick, or until the infant is at least 12 months old. Additional subjects 
were collected from a 2015 database of abnormal modified barium swallow study results.  
We manually reviewed the electronic medical record to confirm that subjects 
were eligible for inclusion into our study. We included subjects meeting the study criteria 
(under the age of 1-year old (0 to 12 months) corrected age at the date that SimplyThick 
was started for the first time at BCH from dates October 1, 2012 to December 31, 2015). 
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We excluded patients who had developed necrotizing enterocolitis before the use 
of SimplyThick. This was because after an initial NEC episode, the subject could 
experience symptoms of NEC again.  
 
Data Collection Process  
We collected data from two electronic databases: 1) electronic medical records, 
using i2B2 and PowerChart; and 2) an existing quality improvement database of infants 
who had an abnormal modified barium swallow result. Data about each patient was either 
generated from the i2B2 results or manually searched throughout a patient’s chart in 
PowerChart.  We collected information regarding clinical variables (e.g. patient age, 
patient sex, patient weight, gestational age at birth, clinical indications), nutritional 
information, and outcomes (presence of NEC or other adverse effects).  If a patient’s 
mean caloric intake per day is not noted in the chart, the average mean caloric intake for 
that corrected age of child was assumed to calculate the specific amount given. We used 
REDCap software to design a data abstraction form to record baseline and medical 
history including detailed information regarding usage of SimplyThick, including 
indications, thickness prescribed, duration of use, and reasons for cessation. We 
examined clinical outcomes through 12 months old or at least 6 months after the use of 
SimplyThick.  
The Vermont Oxford Definition of NEC was used to determine the diagnosis or 
suspicion of NEC (Drenckpohl, 2010). This established definition as well as one 
additional radiographic finding (dilated loops of bowel) was used to identify NEC in 
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patient charts (Beal et al., 2011, Neu et al., 2011, Thompson et al., 2008). The various 
criteria for diagnosing NEC for this study are shown below in Table 4. In addition to 
these symptoms and findings, staging was also evaluated in those suspected or diagnosed 
with NEC. Staging criteria can be found in Table 3. 
 
Table 4. Clinical Signs and Radiographic Findings indicating Necrotizing Enterocolitis. Partially Taken from 
the Vermont Oxford Definition of Necrotizing Enterocolitis (Resource). Going off the Vermont Oxford Definition 
of NEC, if a patient presents with one or more of the following clinical signs as well as one of more of the findings, the 
patient can be diagnosed as having NEC.  
 
Clinical Signs  Radiographic Signs  
Bilious gastric aspirate  Pneumatosis intestinalis  
Bilious emesis  Hepatobiliary gas  
Abdominal distention Pneumoperitoneum 
Occult blood in the stool  Dilated loops of bowel  
Gross blood in the stool  
 
In addition to assessing the clinical signs and radiographic findings of each 
patient, we also looked to see if the subject had been billed for the diagnosis of NEC. The 
ICD 9/ ICD 10 codes for NEC are 777.5 and K55.30, respectively.  
 	
Statistical Analysis 
Descriptive analyses were performed in order to determine counts and proportions 
for variables of interest.  Bivariate chi-square analyses were not performed due to the 
limited sample size. Data were assessed to see if there were any differences in the onset if 
adverse effects (if applicable) and indications for using SimplyThick among age, sex and 
prematurity.  Statistics were performed using Microsoft Excel and SAS software. 
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Aim 1: We used descriptive statistical analysis to describe clinical characteristics of 
patients receiving SimplyThick and other thickeners.  
 
Aim 2: We used descriptive statistics, t-tests, or chi-square tests to describe the 
relationship between usage of SimplyThick (and other thickeners) and NEC and adverse 
effects.   
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E. RESULTS 
Participant Selection 
 Out of 70 reviewed subjects identified through i2b2 who were prescribed 
SimplyThick between the dates October 1, 2012 to December 31, 2015, 17 were eligible 
to meet our criteria of also being under the age of 12 months. We excluded 52 subjects, 
including 45 who were over 1 year of age when prescribed and/or used the SimplyThick 
and 7 who never actually used SimplyThick.  
 Out of 84 reviewed subjects from a medical record number data collection of 
patients who had MBS tests, 22 used SimplyThick. We excluded 19 subjects who were 
older than 1 year of age at the start date, leaving 3 subjects eligible for our study. 
Because our data collection ended February 24th, 2016, we have completed 
preliminary descriptive and bivariate analyses for this project on 20 subjects. Results of 
the preliminary analyses are presented below.  
 
Demographic and Clinical Characteristics  
 Table 5 below shows the demographic and epidemiologic characteristics of the 
subjects included in the study. Of the 20 subjects in this study, 60% were male and 40% 
were female. 30% of subjects were born prematurely, with 75% of the subjects having 
normal birth weight.  
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Table 5. Demographic Characteristics. 
Demographic Characteristics N (%) 
Birth Weight 
Extremely Low Birth Weight (<1000g) 
Very Low Birth Weight (1000g-1499g) 
Low Birth Weight (1500g-2499g) 
Normal Birth Weight (≥2500g) 
 
2 (10) 
0 (0) 
3 (15) 
15 (75) 
Prematurity 
Yes (<37 weeks gestation) 
No (≥37 weeks gestation) 
 
6 (30) 
14 (70) 
Sex 
Female 
Male 
 
8 (40) 
12 (60) 
 
 
Indications for SimplyThick 
 The most common indication for use of SimplyThick was an abnormal modified 
barium swallow study. The MBS results gave the speech pathologists and GI specialists 
definitive visualization of aspiration and/or dysphagia and the consistency of thickened 
liquid feeds necessary to protect against aspiration or promote safe swallowing.  “Other” 
indications for SimplyThick use included laryngomalacia, which is an abnormality of the 
laryngeal cartilage which leads to airway obstruction during inhalation and left vocal cord 
paralysis. Subjects could have more than one indication for SimplyThick. Table 6 shows 
common indications for SimplyThick. 
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Table 6.  Indications for SimplyThick. Below are the percentages of subjects who had each primary indication for use 
of SimplyThick.  
 
Primary Indication for SimplyThick  N(%) 
Aspiration documented on modified barium swallow  19 (95) 
Dysphagia, Swallowing Problems  8 (40) 
GERD 6 (30) 
GER 4 (20) 
Aspiration suspected by clinical exam without modified barium 
swallow  
3 (15) 
Oral Motor Dyscoordination affecting suck, swallow, breathe 
sequence  
3 (15) 
Other  3 (15) 
Chronic Lung Disease/ Bronchopulmonary Dysplasia  1 (5) 
Pneumonia, unspecified  0 (0) 
 
 
Using SimplyThick  
The mean corrected age at which the 20 subjects started SimplyThick was 6.2 months 
old. The minimum age was 2.7 months old and the maximum age was 10.6 months. The 
majority of these subjects were around the age of 3-6 months, which was 40% of the 
subjects. In cases that eventually stopped using SimplyThick (14 cases, 70%), 
SimplyThick was continued for a mean duration of 42.1 weeks (range 1.1 to 117.1 
weeks). The shortest duration was 1.1 weeks. The median duration of SimplyThick use 
among those who stopped using it was 49.7 weeks, or about 12.4 months.  
Half of patients who eventually stopped SimplyThick did not change the 
thickness of feeds prior to stopping. 14.3% started had a weaning regimen before ending 
the SimplyThick use, 28.6% changed to a thinner consistency, 7.1% actually increased 
their thickness, and 50% stayed the same.  The average corrected age at the time of 
stopping SimplyThick was 15.6 months old. 
	31 
Six subjects were still using the SimplyThick at the time of last contact or follow-
up, a mean age of 34.4 months (range 12.8 months to 57.0 months). 50% of those who 
remained on SimplyThick had no change in consistency and 50% changed to a thicker 
consistency. The 6 subjects who continued using SimplyThick had medical histories of 
chronic respiratory problems, autism, paralysis of vocal cord, and multiple congenital 
abnormalities which required them to stay on thickened liquids and certain foods with 
SimplyThick.  
 
Table 7. Timeline on SimplyThick.  
SimplyThick Timeline  n (%) 
Corrected Age (months) at the time that SimplyThick was started 
<3 months 
3 - <6 months  
6 - <9 months  
>9 months  
 
1 (5)  
9 (45) 
6 (30) 
4 (20) 
Change in Consistency (those who stopped, n=14) 
No Change 
To a thicker consistency  
To a thinner consistency  
To a weaning protocol  
 
7 (50) 
1 (7.14) 
4 (28.57) 
2 (14.29) 
Change in Consistency (those who have not stopped, n=6) 
No Change 
To a thicker consistency  
To a thinner consistency  
To a weaning protocol 
 
3 (50) 
3 (50) 
0 (0) 
0 (0) 
Corrected Age (months) SimplyThick Stopped [14 subjects 
stopped] 
3 - <6 months  
6 - <9 months  
>9 months 
 
2 (14.29) 
1 (7.14) 
11 (78.57) 
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Reasons for Stopping SimplyThick 
Of the 20 subjects, 6 subjects, or 30% did not stop using SimplyThick. The majority of 
the remaining 70% of the subjects stopped the SimplyThick because they no longer 
needed thickened feeds or for some other reason. Other reasons for stopping SimplyThick 
included the subject refusing to feed from the bottle, severe swallowing difficulties which 
resulted in the subject needing enteral feeds, one subject vomiting from enteral feeds and 
the family chose to stop oral feeds, the inability to get SimplyThick at the pharmacy or 
the patient was admitted to the hospital for symptoms unrelated to SimplyThick and 
started a new diet after. 1 subject changed to another thickener because it was easier for 
the family to attain.  None of the 14 patients who stopped using SimplyThick did so due 
to an adverse reaction, the cost, or the parents actively choosing against this type of 
thickener.  
 
Table 8. Reasons for Stopping SimplyThick. Below are the reasons that patients stopped the use of SimplyThick and 
their respective percentages.  
 
Reasons for Stopping SimplyThick Frequency (Percentage)  
No longer needed thickened feeds  7 (50) 
Other  6 (42.86) 
Changed to another thickener  1 (7.14) 
Adverse Reaction 0 (0) 
Too Expensive  0 (0) 
Parents no longer wanted SimplyThick  0 (0) 
 
 
Comparing the primary indications amongst those who stopped using SimplyThick and 
those who remained using the thickener, the indications rarely varied and determined if 
the subjects would either stop or continue the use. The major differing indication is that 
of those subjects with dysphagia. 50% of the subjects who stopped using SimplyThick 
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had an indication of dysphagia with only 16.7% of the patients who remained on 
SimplyThick had this indication. “Other” primary indications were present in those who 
stopped SimplyThick eventually but in those who continued.  
 
Table 9. Comparing the Primary Indications of Subjects Who Stopped and did not Stop SimplyThick. 
 
 Those who Stopped use of 
SimplyThick 
n (%) 
Those who did not stop 
using SimplyThick 
n (%) 
Indications for Simply 
Thick: 
Dysphagia  7 (50) 1 (16.7) 
GERD 4 (28.6) 2 (33.3) 
GER 3 (21.4) 1 (16.7) 
Aspiration with MBS 13 (92.9) 6 (100) 
Aspiration without MBS  3 (21.4) 1 (16.7) 
Chronic Lung Disease  1 (7.1) 0 (0) 
Pneumonia  0 (0) 0 (0) 
Oral Motor 
Dyscoordination  
2 (14.3) 1 (16.7) 
Other 3 (21.4) 0 (0) 
 
 
NEC and SimplyThick  
Prior to the initiation of SimplyThick, a few patients did exhibit classical signs of 
NEC such as bilious emesis, abdominal distention, gross blood in the stool, and dilated 
loops of bowel. Reasons for these signs and symptoms commonly associated with NEC 
were allergic colitis, gastroenterocolitis, gastritis, new ketogenic diets and Clostridium 
difficile. These results are below on Table 10.  
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Table 10. Possible Signs of NEC before the use of SimplyThick.  
 
Conditions Before Using SimplyThick Frequency (Percent) 
NEC  0 (0) 
Clinical Signs:  
      Gross blood in the stool  
      Bilious emesis  
      Abdominal distention 
      Occult blood in the stool  
      Bilious gastric aspirate 
 
3 (15) 
2 (10) 
2 (10) 
0 (0) 
0 (0) 
Radiographic Findings:  
      Dilated loops of bowel 
      Pneumatosis intestinalis  
      Hepatobiliary gas   
      Pneumoperitoneum 
       
 
1 (5) 
0 (0) 
0 (0) 
0 (0) 
 
 
There was no diagnosed NEC in any of the 20 subjects who used SimplyThick, 
either before or after the initiation of SimplyThick. Thorough chart review was 
performed to assess if any cases of NEC were misdiagnosed or unnoticed, so the clinical 
signs and radiographic findings associated with NEC were separately searched for in the 
charts. There was also no presence of the either clinical signs or radiographic findings in 
these patients. 
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F. DISCUSSION 
  
The majority of the subjects were full term infants who had a normal birth weight. 
Although the most common indication for SimplyThick was the failed modified barium 
swallow test, other swallowing problems, GERD, laryngomalacia and left vocal cord 
paralysis were also reasons for the recommendation and/or prescription of SimplyThick.  
 In the 20 study subjects, SimplyThick appeared to be well-tolerated.  None of the 
subjects developed NEC, or at least they did not develop it at BCH. Of the 14 (70%) 
patients who stopped using SimplyThick, the major reasons for stopping included no 
longer needing thickened feeds, or changing to another thickener. A small minority of 
those who stopped did so because the subject refused to feed from the bottle, the subject 
had severe swallowing difficulties which resulted in the subject needing enteral feeds, 
one subject vomiting from enteral feeds and the family chose to stop oral feeds, the 
inability to get SimplyThick at the pharmacy or the patient was admitted to the hospital 
for symptoms unrelated to SimplyThick and started a new diet after. The vomiting was 
determined by the medical team to be unrelated to the use of SimplyThick since it 
occurred even after SimplyThick was discontinued and was concluded to be an adverse 
effect of the subject’s G-tube.  
 Six of the 20 subjects were still using SimplyThick at the end of study follow-up, 
and these patients had been using SimplyThick for a mean of 42.1 weeks (range 1.1 to 
117.1 weeks) without adverse effects.   
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 Since there were no adverse effects detected in the subjects after using 
SimplyThick, we were not able to examine whether age at initiation of SimplyThick use, 
sex or prematurity increased or decreased the risk of adverse effects. Current research 
speculates that the risk of NEC is greater for male infants and in premature infants 
(Drenckpohl et al., 2010), and in the published case reports of NEC in infants who used 
SimplyThick, a substantial proportion were born premature.  With further data collection, 
we hope to further assess the safety profile of SimplyThick and whether age at initiation 
or prematurity, are associated with increased likelihood of adverse effects. 
  
Limitations  
One limitation of this study includes its retrospective nature which is dependent 
on clinician-recorded data in the patient chart. Another limitation of this study is that we 
may have missed inclusion of some infants who could have used SimplyThick without a 
prescription, order or mention from their physician. Another limitation of this study is the 
inability to account for all potential confounders.  For example, probiotics added to 
certain formulas could be protective against NEC.  However, whether a formula 
consumed by a subject contains a probiotic, was not consistently recorded in the medical 
record.   
Additional limitations include the varying duration of follow-up, possible 
selection bias and small sample size. One case was at BCH for a very short period (<6 
months) and no records were collected to document the case’s outcomes after using 
SimplyThick. Only using the i2B2 and MBS test subjects could have resulted in selection 
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bias and some patients who used SimplyThick could have been excluded without our 
knowledge from the study. Given the small sample size of 20 cases, further data 
collection is needed to confirm our findings.  
 
Conclusions and Future Directions 
Of the 20 patients reviewed, none developed necrotizing enterocolitis. This 
finding suggests that NEC is uncommon in infants who use SimplyThick.  Given our 
study’s small sample size, our findings need further confirmation in a larger study. Data 
collection will be ongoing until the original data collection goal is met. If we are able to 
show that NEC is either uncommon or nonexistent in infants at BCH using SimplyThick, 
this finding may allow re-evaluation by clinicians of the indications and age at which 
SimplyThick can be safely used.  
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